Abstract
Maintenance of Health-Related Quality of Life in the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase Chronic Myeloid Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have